I’m not sure about the ‘no competition thing’ https://renovorx.com/ has Renovo ever been discussed? They have achieved very similar OS results if 4-5 months of induction chemo is added. Gem is a much milder drug than FOLFIRINOX. 6-8 intra-arterial infusions. Side effects reduced. Phase III almost complete. Multiple pathways for reimbursement in the US. Trading very low, however.
- Forums
- ASX - By Stock
- OSL
- Sales projections
OSL
oncosil medical ltd
Add to My Watchlist
5.26%
!
$1.00

Sales projections, page-66
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.00 |
Change
0.050(5.26%) |
Mkt cap ! $13.51M |
Open | High | Low | Value | Volume |
$1.00 | $1.00 | $1.00 | $46 | 46 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 14217 | $1.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 13831 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 45 | 1.045 |
2 | 123 | 1.000 |
1 | 5 | 0.960 |
2 | 16677 | 0.950 |
1 | 819 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 46 | 2 |
1.090 | 375 | 1 |
1.150 | 2548 | 2 |
1.190 | 9813 | 2 |
1.200 | 65603 | 3 |
Last trade - 10.06am 18/06/2025 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online